Marshall Wace, LLP Dare Bioscience, Inc. Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.94 - $1.76 $69,259 - $129,676	-73,680 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.42 - $2.09 $1.87 Million - $2.75 Million	-1,314,882 Reduced 94.69%	73,680 $110,000
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $1.97 Million - $2.96 Million	1,388,562 New	1,388,562 $2.78 Million

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.